FDA clears Cymbalta to treat chronic musculoskeletal pain

Share this content:
The Food and Drug Administration recently approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. The recommended dose for Cymbalta is a 60 milligram capsule taken once daily without regard to meals. The capsule should be swallowed whole, and not chewed, crushed or opened; the contents should never be sprinkled on food or mixed with liquids. Cymbalta was first used to treat major depressive disorder in 2004. Eli Lilly and Co. makes the medication.